MaxQ AI’s ICH and stroke software to be available on Philips CT systems

MaxQ AI has announced that its AI-based intracranial hemorrhage (ICH) and stroke software will soon be integrated into Philips CT scanners. The first round of deployments is expected in 2020.

MaxQ AI’s Accipio ICH and stroke platform uses deep learning to evaluate medical images and automatically identify those that show signs of ICH. The platform will be available for the newest line of Philips CT systems and can be installed as an upgrade to existing equipment.

“Through this powerful collaboration, we will empower physicians to better identify and prioritize patients with a suspected ICH, which have the potential to save lives, improve the quality of care, and lower healthcare costs,” Gene Saragnese, CEO of MaxQ AI, said in a prepared statement.

“We are advancing patient care by co-creating with our customers to bring innovations in CT system design, workflow, radiation dose management, image quality, advanced clinical applications and improved total cost of ownership,” Karim Boussebaa, general manager of computed tomography and advanced molecular imaging at Philips, said in the same statement. “As healthcare continues to transform from a volume- to a value-based approach, and the amount of data available for each clinical decision dramatically grows, the integration of MaxQ's Accipio AI-powered solutions with our CT systems supports our ambition to achieve the quadruple aim: improved outcomes, enhanced patient experience, increased staff satisfaction, and lowered cost of care delivery.”

Michael Walter
Michael Walter, Managing Editor

Michael has more than 19 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

Suman Tandon, MD, an American Society of Nuclear Cardiology board member, explains the group's call on Congress to update a number of healthcare policies. 

The 2026 MPFS proposed rule includes higher conversion factors across the board. However, some cardiology groups remain concerned about a series of reimbursement reductions for high-value cardiology services. 

The Heart Rhythm Society and its new advocacy arm plan on pushing CMS to include certain policy improvements in the 2026 MPFS.